Skip Navigation
Skip to contents



15 results

Reply to Commentary on "A Nationwide Survey of Knowledge of and Compliance with Cancer Pain Management Guidelines by Korean Physicians"

Kim DY, Kim SY

  • Cancer Res Treat.
  • 2014 Oct;46(4):426-426.
  • doi: 10.4143/crt.2014.123R
No abstract available.
Commentary on "A Nationwide Survey of Knowledge of and Compliance with Cancer Pain Management Guidelines by Korean Physicians"

Walsh K

  • Cancer Res Treat.
  • 2014 Oct;46(4):425-425.
  • doi: 10.4143/crt.2014.123C
No abstract available.
Bladder and Liver Involvement of Visceral Larva Migrans May Mimic Malignancy

Kang EJ, Choi YJ, Kim JS, Lee BH, Kang KW, Kim HJ, Yu ES, Kim YH

  • Cancer Res Treat.
  • 2014 Oct;46(4):419-424.
  • doi: 10.4143/crt.2013.104
Visceral larva migrans (VLM) syndrome is a clinical manifestation of systemic organ involvement by Toxocara species. VLM with involvement of the bladder and liver is a rare finding. A 62-year-old...
Pleural Metastasis as Initial Presentation of Occult Gastric Cardia Cancer: A Possible Role of PET-CT in Diagnosis

Yoon SY, Kim JH, Kim WS, Chung HW, Lee MH, Kim SY, Cho YH

  • Cancer Res Treat.
  • 2014 Oct;46(4):415-418.
  • doi: 10.4143/crt.2013.068
We report on a case of malignant pleural effusion as initial metastatic presentation of occult gastric cardia cancer in a young woman. To the best of our knowledge, this is...
A New Approach to the Treatment of Metastatic Paraganglioma: Sorafenib

Gunaldi M, Kara IO, Duman BB, Afsar CU, Ergin M, Avci A

  • Cancer Res Treat.
  • 2014 Oct;46(4):411-414.
  • doi: 10.4143/crt.2013.093
Paragangliomas are relatively rare chromaffin cell tumors which may be cured through resection. Patients with paragangliomas may develop metastatic diseases. There is no consensus regarding refractory chemotherapy for treatment of...
Analysis of Biologically Equivalent Dose of Stereotactic Body Radiotherapy for Primary and Metastatic Lung Tumors

Park S, Urm S, Cho H

  • Cancer Res Treat.
  • 2014 Oct;46(4):403-410.
  • doi: 10.4143/crt.2013.168
PURPOSE: The purpose of this study was to determine the optimal biologically equivalent dose (BED) for stereotactic body radiotherapy (SBRT) by comparing local control rates in proportion to various total...
Ultra-Low-Dose Chest CT in Patients with Neutropenic Fever and Hematologic Malignancy: Image Quality and Its Diagnostic Performance

Kim HJ, Park SY, Lee HY, Lee KS, Shin KE, Moon JW

  • Cancer Res Treat.
  • 2014 Oct;46(4):393-402.
  • doi: 10.4143/crt.2013.132
PURPOSE: The aim of this study was to evaluate the image quality of ultra-low-dose computed tomography (ULDCT) and its diagnostic performance in making a specific diagnosis of pneumonia in febrile...
p27 Loss Is Associated with Poor Prognosis in Gastroenteropancreatic Neuroendocrine Tumors

Kim HS, Lee HS, Nam KH, Choi J, Kim WH

  • Cancer Res Treat.
  • 2014 Oct;46(4):383-392.
  • doi: 10.4143/crt.2013.102
PURPOSE: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent a heterogeneous disease group originating from the neuroendocrine cells. Identification of prognostic markers, related to neuroendocrine tissue-selective tumorigenesis, is necessary to find therapeutic targets. MATERIALS...
Is Prophylactic Irradiation to Para-aortic Lymph Nodes in Locally Advanced Cervical Cancer Necessary?

Park SG, Kim JH, Oh YK, Byun SJ, Kim MY, Kwon SH, Kim OB

  • Cancer Res Treat.
  • 2014 Oct;46(4):374-382.
  • doi: 10.4143/crt.2013.084
PURPOSE: This study evaluated the efficacy of extended field irradiation (EFI) in patients with locally advanced cervical cancer without para-aortic nodal involvement. MATERIALS AND METHODS: A total of 203 patients with...
Clinical Characteristics and Adequate Treatment of Familial Adenomatous Polyposis Combined with Desmoid Tumors

Jung WB, Kim CW, Kim JC

  • Cancer Res Treat.
  • 2014 Oct;46(4):366-373.
  • doi: 10.4143/crt.2013.185
PURPOSE: The objective of this study was to examine the clincopathologic characteristics and outcomes of familial adenomatous polyposis (FAP) patients with and without desmoid tumors (DTs), including the risk factors...
Clinical Outcome of Relapsed or Refractory Burkitt Lymphoma and Mature B-Cell Lymphoblastic Leukemia in Children and Adolescents

Kim H, Park ES, Lee SH, Koo HH, Kim HS, Lyu CJ, Jun SE, Lim YT, Baek HJ, Kook H, Lee JW, Kang HJ, Park KD, Shin HY, Ahn HS

  • Cancer Res Treat.
  • 2014 Oct;46(4):358-365.
  • doi: 10.4143/crt.2013.047
PURPOSE: Despite the rapid improvement in survival rate from Burkitt lymphoma and mature B-cell lymphoblastic leukemia (B-ALL) in children, a small subset of patients do not respond to first-line chemotherapy...
Multicenter Validation Study of a Prognostic Index for Portal Vein Tumor Thrombosis in Hepatocellular Carcinoma

Yu JI, Yoon SM, Park HC, Kim JH, Kim TH, Park JW, Seong J, Lee IJ, Jang HS, Kay CS, Kim CY, Chie EK, Kim JH, Kim MS, Choi YM

  • Cancer Res Treat.
  • 2014 Oct;46(4):348-357.
  • doi: 10.4143/crt.2013.142
PURPOSE: We previously reported on a staging system and prognostic index (PITH) for portal vein tumor thrombosis (PVTT) in hepatocellular carcinoma (HCC) patients treated with radiotherapy (RT) at a single...
Efficacy and Safety of Everolimus in Korean Patients with Metastatic Renal Cell Carcinoma Following Treatment Failure with a Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor

Park K, Lee JL, Ahn JH, Lee KH, Jeong IG, Song C, Hong B, Hong JH, Ahn H

  • Cancer Res Treat.
  • 2014 Oct;46(4):339-347.
  • doi: 10.4143/crt.2013.154
PURPOSE: The purpose of this study is to assess the efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma (mRCC) for whom initial treatment with a...
Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study

Shin SH, Lee HS, Kim YS, Choi YJ, Kim SH, Kwon HC, Oh SY, Kang JH, Sohn CH, Lee SM, Baek JH, Min YJ, Kim C, Chung JS

  • Cancer Res Treat.
  • 2014 Oct;46(4):331-338.
  • doi: 10.4143/crt.2013.130
PURPOSE: To evaluate the efficacy of hydromorphone-OROS (HM-OROS) in reducing sleep disturbance and relieving cancer pain. MATERIALS AND METHODS: One hundred twenty cancer patients with pain (numeric rating scale [NRS] >...
Nomogram Predicting Clinical Outcomes in Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Keam B, Kim DW, Park JH, Lee JO, Kim TM, Lee SH, Chung DH, Heo DS

  • Cancer Res Treat.
  • 2014 Oct;46(4):323-330.
  • doi: 10.4143/crt.2013.120
PURPOSE: The aim of this study was to develop a pragmatic nomogram for prediction of progressionfree survival (PFS) for the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: